What is new in melanoma research? Vaccines, Basic and Translational Research in 2003: report of a workshop at the Third Research Meeting on Melanoma, Milan, Italy, May 2003.
During the session on Vaccines, Basic and Translational Research at the Third Research Meeting on Melanoma, Milan, Italy, held in May 2003, many questions regarding the development of new immunotherapeutical strategies for the treatment of melanoma and more basic research on tumorigenesis, as well as new prognostic markers for disease progression, were addressed. This report briefly summarizes some of the highlights and themes of this session.
Rescigno
Maria
M
Department of Experimental Oncology, European Institute of Oncology, Milan, Italy. maria.rescigno@ieo-research.it
Testori
Alessandro
A
Parmiani
Giorgio
G
D014408:Biomarkers, Tumor / Q000097:blood; D035843:Biomedical Research; D019496:Cancer Vaccines / Q000627:therapeutic use*; D006801:Humans; D007558:Italy; D008545:Melanoma / Q000097:blood / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy*; D011379:Prognosis
D014408:Biomarkers, Tumor; D019496:Cancer Vaccines